Europe and israel mobile applications for melanoma detection market

Melanoma is a cancer occurring in melanocytes, which are cells that create melanin pigment, and is a highly heterogeneous disease. Some of the various types of melanoma include cutaneous melanoma (CM), mucosal melanoma (MM), ocular melanoma (OM), melanoma of the internal organs, and melanoma of the soft parts of the body.

Europe and Israel mobile applications for melanoma detection market is estimated to be valued at US$ 1.1 million in 2021 and is expected to exhibit a CAGR of 19.6 % over the forecast period (2021-2028).

Recent Developments:

In August 2021, Digital Diagnostics (formerly known as IDx) has acquired dermatology focused startup 3Derm. In 2018 Digital Diagnostics landed a De Novo to market its AI-based software system for the autonomous detection for diabetic retinopathy in adults who have diabetes named IDx-DR.

In September 2020, Skin Analytics, a U.K.-based startup that has developed a skin cancer screening service that uses artificial intelligence, has raised £4 million in Series A funding. The round was led by Hoxton Ventures, with participation from Nesta and Mustard Seed Ventures.

In October 2019, a study published in the Journal of the European Academy of Dermatology and Venereology, investigators tested the app’s claimed that SkinVision app can play a crucial role in early skin cancer detection. They concluded that it is around 95.1% sensitive in its ability to identify the most common forms of skin cancer

Europe held dominant position in Europe and Israel Mobile Application for Melanoma market in 2020, accounting for 95.4% share in terms of value, followed by Israel. Dominance of Europe region in Europe and Israel Mobile Application for Melanoma market in 2020 can be attributed to growing prevalence of melanoma, increasing adoption of AI bases smart application for detection, and higher penetration of internet & smart phones in the region.

Figure 1. Europe and Israel Mobile Applications for Melanoma Detection Market Value (US$ Mn), by Region, 2020

Europe and Israel Mobile Applications for Melanoma Detection Market: Drivers

Increasing prevalence of melanoma is expected to propel growth of the Europe and Israel mobile applications for melanoma detection market over the forecast period. For instance, according to Globocan 2018, there were 144,000 new cases / year in Europe and the disease resulted in 27,000 deaths / year in the region.

Moreover, increasing adoption of smartphones is also expected to aid in growth of the market. For instance, according to The Office of Communications, the U.K. government-approved regulatory and competition authority for the broadcasting, telecommunications and postal industries, seventy-two per cent of adults say their smartphone is their most important device for accessing the internet, 71% say they never turn off their phone, and 78% say they could not live without it (2018 Data).

Europe and Israel Mobile Applications for Melanoma Detection Market: Opportunities 

Increasing penetration of internet is expected to offer lucrative growth opportunities for players in the Europe and Israel mobile applications for melanoma detection market. For instance, according to The Office of Communications, the U.K. government-approved regulatory and competition authority for the broadcasting, telecommunications and postal industries, the proportion of people accessing the internet on their mobile increased from 20% in 2008 to 72% in 2018. The average amount of time spent online on a smartphone is 2 hours 28 minutes a day. This rises to 3 hours 14 minutes among 18-24s.

Moreover, R&D in skin cancer application is also expected to aid in growth of the market. For instance, in September 2019, researchers at Erasmus University Medical Center, Netherlands, reported that SkinVision—the first CE-marked skin cancer application based on extensive clinical trials—has a sensitivity of 95.1% in detecting the most common forms of skin cancer.

Market Trends

Development of new technologies is expected to propel growth of the Europe and Israel mobile applications for melanoma detection market. For instance, in December 2019, Denmark-based company Miiskin reported development of AI-powered skin mapping technology to detect early warning signs of melanoma.

The market in Europe is witnessing approval and launch of new therapies. For instance, in May 2020, OncoSec Medical Inc., a company developing late-stage intratumoral cancer immunotherapies, received the European Medicines Agency’s advanced therapy medicinal product certificate for chemistry manufacturing controls data covering its lead product candidate, TAVO (interleukin-12 or "IL-12" plasmid), for the treatment of metastatic melanoma.

Figure 2. Global Europe and Israel Mobile Applications for Melanoma Detection Market Share, By Type, 2020

Key Takeaways of the Graph:

• Among type, the Algorithm Analysis Application held dominant position in the market and accounted for 45.4% share in Europe and Israel mobile applications for melanoma detection market in 2020. The segment is expected to reach US$ 1.85 million in 2028.
• Algorithm Analysis applications are used for risk assessment of pigmented moles, low cost, easy accessibility, and convenient to use are some of the major features to drive this segment during the forecast period
• Among End User, the Patients held dominant position in the market and accounted for 37.7% share in Europe and Israel mobile applications for melanoma detection market in 2020. The segment is expected to reach US$ 1.51 million in 2028.
• Dominance of patients segment can be ascribed to growing demand of mobile applications for melanoma detection among individual end users, easy accessibility for internet & smart phones, and new product launches for mobile users.

Europe and Israel Mobile Applications for Melanoma Detection Market: Restraints

Concerns regarding accuracy of mobile applications for melanoma detection is expected to hinder growth of the Europe and Israel mobile applications for melanoma detection market. For instance, in February 2020, researchers from University of Birmingham and University of Warwick, U.K., reported that current algorithm based smartphone apps cannot be relied on to detect all cases of melanoma or other skin cancers.

Moreover, regulations related to mobile applications for melanoma detection have become more stringent and the concerned application vendors/developers have to undergo costly regulatory procedures. Such scenario is also expected to limit the market growth.

Europe and Israel Mobile Applications for Melanoma Detection Market: Competitive Landscape

Major players operating in the Europe and Israelmobile applications for melanoma detection market include, SkinVision, DermaCompare, Dermatology Planet, DermLink.MD, Doctor Mole, FotoSkin, iDoc24, iSkin, LoveMySkin, and Melanoma Calculator.

Europe and Israel Mobile Applications for Melanoma Detection Market: Key Developments

October 2019: SkinVision, achieved three ISO certifications. The British Standards Institution (BSI), awarded SkinVision ISO 13485:2016 for its quality management system. BSI awarded the company ISO 27001:2013 for information security management, as well as the Dutch national standard NEN 7510:2017, which includes additional requirements to ISO 27001:2013, specifically for healthcare providers in the Netherlands.